We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DCI:NYSEDonaldson Company, Inc. Analysis

Data as of 2026-06-13 - not real-time

$86.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Donaldson Company (DCI) trades at $86.4, below its 20‑day SMA of 83.74 and 50‑day SMA of 85.81, yet still under the 200‑day SMA of 88.82, indicating a short‑term bearish bias within a longer‑term downtrend. The RSI sits at 55, suggesting neutral momentum, while the MACD histogram is positive (+0.42) and the signal line is bullish, hinting at a potential near‑term reversal. Volatility is elevated at 26% over the past 30 days, but beta of 0.91 points to lower systematic risk than the market. Fundamentals are solid: revenue grew 5.8% YoY to $3.81 B, operating margin stands at 16.3%, and free cash flow exceeds $300 M, supporting a sustainable dividend yield of 1.41% with a modest 32% payout ratio. Valuation appears attractive – the trailing P/E of 23.3 is well below the industry average of 30.6, and analysts project a 12% upside to a mean target of $96.8. Recent earnings beat expectations and an announced 6.7% dividend increase reinforce confidence in the company’s growth trajectory and cash generation capabilities.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near resistance at $87.64
  • Positive MACD histogram suggesting short‑term momentum
  • Upcoming earnings release could clarify trend direction

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to peers (P/E 23 vs industry 30.6)
  • Analyst consensus target price implying ~12% upside
  • Strong cash flow and sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified filtration segments with secular demand growth
  • Consistent dividend growth and low payout ratio
  • Robust balance sheet and modest debt level enabling strategic investments

Key Metrics & Analysis

Financial Health

Revenue Growth5.80%
Profit Margin11.53%
P/E Ratio23.3
ROE27.78%
ROA12.03%
Debt/Equity35.88
P/B Ratio5.9
Op. Cash Flow$461.6M
Free Cash Flow$302.4M
Industry P/E30.6

Technical Analysis

TrendBearish
RSI55.2
Support$79.61
Resistance$87.64
MA 20$83.74
MA 50$85.81
MA 200$88.82
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$40.78
Target Price$96.80
Upside/Downside12.04%
GradeUndervalued
TypeBlend
Dividend Yield1.41%

Risk Assessment

Beta0.91
Volatility26.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.